This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The Rockefeller University, Bristol-Myers Squibb Compnay. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 751 
1 out of 3,745 
Years Active: 2019-2026
Title: Rony Dahan: Innovator in Antibody Development
Introduction
Rony Dahan is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of antibody research. With a total of three patents to his name, Dahan has made strides in developing innovative therapeutic solutions.
Latest Patents
Among his latest patents is the invention of antibodies to CD40 with enhanced agonist activity. These agonistic antibodies, or antigen-binding portions thereof, specifically bind to human CD40. The antibodies are designed to include Fc regions with enhanced specificity for FcγRIIb. This invention also outlines methods for treating cancer or chronic infections by administering these antibodies to subjects in need.
Career Highlights
Rony Dahan has worked with esteemed organizations such as The Rockefeller University and Bristol-Myers Squibb Company. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Dahan has collaborated with notable colleagues, including Jeffrey V. Ravetch and Bryan C. Barnhart. These partnerships have further enriched his research endeavors and innovations.
Conclusion
Rony Dahan's work in antibody development showcases his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile